Ocugen (OCGN) Times Interest Earned (2014 - 2026)

Ocugen (OCGN) posted Times Interest Earned of -$0.98 for Q1 2026, up 92.28% on a QoQ basis from -$12.76 in Q4 2025, and up 91.47% year-over-year from -$0.51 in Q1 2025.

Ocugen (OCGN) Times Interest Earned (2014 - 2026) Analysis & Trends

Ocugen's Times Interest Earned history runs 13 years deep, the most recent figure standing at -$0.98 for Q1 2026.

  • Quarterly Times Interest Earned rose 91.47% year-over-year to -$0.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.66 (up 87.78% YoY) and the FY2025 annual result came in at -$0.46, down 1.02% from the prior year.
  • Times Interest Earned was -$0.98 for Q1 2026 at Ocugen, up from -$12.76 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$0.1 in Q4 2023 and bottomed at -$456.97 in Q3 2024.
  • A 5-year average of -$32.21 and a median of -$3.74 in 2023 frame the typical range for Times Interest Earned.
  • Annual changes were most pronounced in 2022 — Times Interest Earned soared 99.97% — and 2024, when it sank 22361.42%.
  • Ocugen's Times Interest Earned stood at -$0.24 in 2022, then soared by 57.98% to -$0.1 in 2023, then sank by 22361.42% to -$23.03 in 2024, then jumped by 44.59% to -$12.76 in 2025, then soared by 92.28% to -$0.98 in 2026.
  • Business Quant data shows OCGN's Times Interest Earned at -$0.98 in Q1 2026, -$12.76 in Q4 2025, and -$13.41 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Ocugen 63.79 Mn 63.79 Mn - -0.98

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.98
Dec 31, 2025 -12.76
Sep 30, 2025 -13.41
Jun 30, 2025 -2.17
Mar 31, 2025 -11.54
Dec 31, 2024 -23.03
Sep 30, 2024 -456.97
Jun 30, 2024 -2.79
Mar 31, 2024 -1.97
Dec 31, 2023 -0.10
Sep 30, 2023 -2.80
Jun 30, 2023 -5.09
Mar 31, 2023 -3.74
Dec 31, 2022 -0.24
Sep 30, 2022 -4.83
Jun 30, 2022 -3.87
Mar 31, 2022 -1.32
Dec 31, 2021 -728.60
Sep 30, 2021 -0.22
Jun 30, 2021 -0.43